FOXA1 and prostate cancer: Collectively, these findings establish FOXA1 as a novel HIF1α-interacting partner in prostate cancer cells and suggest that their cooperation under hypoxic conditions may be structurally or contextually regulated, potentially contributing to the reprogramming of transcriptional networks in response to tumor hypoxia.